ORLANDO, Florida — A Paleolithic elimination diet (Wahls diet) or a low-saturated fat diet (Swank diet) are associated with improved cognition, among other clinical outcomes, in relapsing-remitting multiple sclerosis (RRMS), new research suggests. In a randomized study of patients with RRMS, the group that followed a Wahls diet and the group that followed a Swank […]
Home »
ECTRIMS/EAN Statement on COVID-19 Vaccination in MS Patients
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have produced a joint position statement on COVID-19 vaccination for patients with multiple sclerosis (MS). The statement was released on October 13 at […]
A Less Expensive, More Convenient Treatment Option for MS?
Patients with multiple sclerosis (MS) may soon have another less expensive, more convenient treatment option compared with other agents in the same drug class, new research suggests. Results from two new phase 3 trials show that the investigational drug ublituximab (TG Therapeutics), a novel glycoengineered anti-CD20 monoclonal antibody, significantly reduced the annualized relapse rate (ARR) […]
Accident Gives MS Doctor Insight Into Patients’ Lives
Editor’s note: The original text has been revised and updated. As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for his Saturday morning run on Nov. 7, 2020, the world’s weighty problems swirled through his head. Brexit, a U.S. election, a global pandemic, not to mention the daily struggles of […]